Back to Search
BRUCE GIANTONIO, MD
MD
Medical Oncology Physician
NPI: 1255377198IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
MD041905L(PA)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE
Class of 1987
Research & Publications (20)
Targeted therapies: Goldie-Coldman and bevacizumab beyond disease progression.
PMID 19483736·Nat Rev Clin Oncol·2009
8-other
The role of the Eastern Cooperative Oncology Group in establishing standards of cancer care: over 50 years of progress through clinical research.
PMID 18929148·Semin Oncol·2008
6-review
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200.
PMID 17442997·J Clin Oncol·2007
3-trial
Bevacizumab in the treatment of metastatic colorectal cancer (mCRC) in second- and third-line settings.
PMID 17145520·Semin Oncol·2006
6-review
A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the Eastern Cooperative Oncology Group study E2200.
PMID 16873427·Ann Oncol·2006
3-trial
Phase I and pharmacokinetic study of the cytotoxic ether lipid ilmofosine administered by weekly two-hour infusion in patients with advanced solid tumors.
PMID 14977826·Clin Cancer Res·2004
3-trial
Toxicity and response evaluation of the interferon inducer poly ICLC administered at low dose in advanced renal carcinoma and relapsed or refractory lymphoma: a report of two clinical trials of the Eastern Cooperative Oncology Group.
PMID 11291838·Invest New Drugs·2001
3-trial
Bevacizumab: current indications and future development for management of solid tumors.
PMID 19344286·Expert Opin Biol Ther·2009
6-review
Bevacizumab and oxaliplatin-based chemotherapy in metastatic colorectal cancer.
PMID 18471041·Expert Rev Anticancer Ther·2008
6-review
Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil or 5-fluorouracil and oxaliplatin on outcomes in rectal cancer.
PMID 17443718·J Surg Oncol·2007
8-other
Gastrointestinal perforation and cancer therapy: managing risk to achieve benefit.
PMID 15900624·Onkologie·2005
8-other
A phase II trial of gefitinib with 5-fluorouracil, leucovorin, and irinotecan in patients with colorectal cancer.
PMID 15870719·Br J Cancer·2005
3-trial
Phase I trial of combretastatin a-4 phosphate with carboplatin.
PMID 15746056·Clin Cancer Res·2005
3-trial
Concurrent RT with 5-FU/epirubicin and cisplatin or irinotecan for locally advanced upper GI adenocarcinoma.
PMID 15685833·Oncology (Williston Park)·2004
3-trial
Evaluating antiangiogenesis agents in the clinic: the Eastern Cooperative Oncology Group Portfolio of Clinical Trials.
PMID 14977816·Clin Cancer Res·2004
8-other
Phase I trial of UFT/leucovorin and irinotecan in patients with advanced cancer.
PMID 14962716·Eur J Cancer·2004
3-trial
Phase I trial of the antifolate ZD9331 in combination with cisplatin in patients with refractory solid malignancies.
PMID 14722734·Cancer Chemother Pharmacol·2004
3-trial
Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow.
PMID 14645433·J Clin Oncol·2003
3-trial
Vinblastine and estramustine phosphate in metastatic renal cell carcinoma: a phase II trial of the Fox Chase Network.
PMID 14584064·Cancer·2003
3-trial
Dose escalation study of tezacitabine in combination with cisplatin in patients with advanced cancer.
PMID 12673728·Cancer·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3400 SPRUCE ST, 15 PENN TOWER
PHILADELPHIA, PA 19104 - Phone
- (215) 662-3914
Quick Facts
- NPI
- 1255377198
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile